CARDIOVASCULAR [bdsy]
Pharmacogenomics [bmod]
Patients [podg]
CKD [dsyn]
Independent [idcn]
Risk factor [qnco]
Cardiovascular disease [dsyn]
Patients [podg]
CKD [dsyn]
Often [tmco]
treatment [ftcn]
Cardiovascular Drugs [phsu]
Antihypertensive [phsu]
Anticoagulant [phsu]
Lipid lowering agents [phsu]
Variability [cnce]
Response [orga]
Cardiovascular therapy [topp]
Contribute [acty]
To [qlco]
Risk [qlco]
treatment failure [qlco]
adverse drug effects [inpo]
Pharmacogenomics [bmod]
Potential [qlco]
CARDIOVASCULAR [bdsy]
Pharmacotherapy [topp]
Outcome [ftcn]
Patients [podg]
Cardiovascular disease [dsyn]
Data [idcn]
Patients [podg]
Concomitant [tmco]
CKD [dsyn]
Limited [ftcn]
Drugs [phsu]
Most [qnco]
pharmacogenomic [bmod]
Evidence [ftcn]
Warfarin [hops, orch, phsu]
clopidogrel [orch, phsu]
Statins [orch, phsu]
Data [idcn]
GENETIC [topp]
Contribution [acty]
Beta-blocker [phsu]
Response [orga]
Guidelines [inpr]
Now [tmco]
Available [ftcn]
assist [socb]
Apply [hlca]
Pharmacogenetic Test [lbpr]
Result [ftcn]
To [qlco]
Warfarin [hops, orch, phsu]
antiplatelet therapy [topp]
Percutaneous Coronary Intervention [topp]
Prediction [idcn]
Risk [qlco]
Statin [orch, phsu]
Induced [ftcn]
Myopathy [dsyn]
Clinical Data [inpr]
Age [orga]
Body Size [orga, qnco]
kidney function [ortf]
Long [qlco]
To [qlco]
Drug Prescribing [hlca]
Increasing [ftcn]
institutions [idcn]
Genetic Testing [lbpr]
considered [idcn]
Context [fndg]
Clinical [qlco]
Factor [ftcn]
Further [spco]
Drug Therapy [topp]
Patients [podg]
Cardiovascular disease [dsyn]
[c] [qnco]
national [inpr]
Kidney [bpoc]
Foundation [orgt]
Rights [qlco]
Reserve [acty]
